COVID-19 in heart transplant recipients – infection rate – clinical course - immunogenity

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023957

Enrollment

1050

Registered

2021-01-22

Start date

2021-02-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid-19 heart transplant Z94.1

Interventions

Group 1: Patients after heart transplantation will receive a questionnaire (topic: knowledge, risk perception, protective behavior and confidence during COVID-19). In case of SARS-COV-2 infection, the

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients after heart transplantation

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The aim is to record the course of heart transplanted patients during the SARS-COV-2 pandemic with regard to risk of infection, clinical course in case of infection as well as course of antibody formation after having undergone infection and, if necessary, after vaccination.	—

Secondary

Measure	Time frame
Observational study/ no defined endpoint/ no intervention	—

Countries

Germany

Contacts

Public ContactHeike Windhagen

Herz- und Diabeteszentrum NRW, Klinik für Thorax- u. Kardiovaskularchirurgie, Universitätsklinikum der Ruhr Universität Bochum

hwindhagen@hdz-nrw.de05731-97-1907

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026